Page 2 - Syncona Ltd News Today

/PRNewswire/ -- Technavio categorizes the global gene therapy market size as estimated to increase by USD 4,613.9 million between 2022 and 2027. The markets...

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed sale of Freeline Therapeutics Holdings plc to Syncona Ltd....

The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: ---------- Saietta Group PLC - Towcester, England-based designer,...

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Freeline Therapeutics Holdings plc to Syncona Ltd. for $6.50 per American Depositary Share is fair to Freeline...

Freeline Therapeutics Holdings Plc (FRLN) said on Wednesday that it has inked a deal to be acquired by the newly established portfolio company, Syncona Ltd (SYNC), for around $28.

London-listed Syncona Ltd has agreed to acquire Freeline Therapeutics Holdings plc (NASDAQ: FRLN) in an all-cash transaction for $6.50 per 

London-listed Syncona Ltd has agreed to acquire Freeline Therapeutics Holdings plc FRLN in an all-cash transaction for $6.50 per American Depositary Share.…

Syncona Ltd ("Syncona" or the "Company"), a leading life science investor focused on creating, building and scaling global leaders in life science, today announces that its newly established portfolio company has entered into an agreement with Freeline Therapeutics Holdings plc ("Freeline") to acquire all of the ...

Syncona Ltd - London-based investor in healthcare companies - Says portfolio company Achilles Therapeutics reports that pretax loss widened to USD16.7 million in the third quarter of 2023 from...